Activation of NF-κB and type I IFN pathways of MyDDosome and MAVSome leads to the nuclear translocation of the NF-κB complex and interferon regulatory factor 3/7 (IRF3/IRF7) to induce the expressions of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and IFNs. Subsequent binding of IFNs to IFNAR [5] and IL-6 to IL-6R-gp130 activate the STAT1/3 pathway [6] and the expression of IFN-stimulated genes and proinflammatory cytokines, ultimately mounting a robust immune response that could be beneficial for pathogen defense. [7] Nevertheless, this host defensive reaction could also cause detrimental tissue injury or severe respiratory syndrome as seen in COVID-19 patients infected with SARS-CoV-2. [8] For example, IFNs stimulate the expression of SARS-CoV-2 entry receptor ACE2 (angiotensin-converting enzyme 2) to favor viral infection and IL-6-induced severe respiratory syndrome. [9,10] The association of ligand with TLR triggers the recruitment of TLR-specific Toll/IL-1R (TIR) domain-containing adaptor protein (TIRAP) on the plasma membrane (PM) (TLR4) and endosomal subdomains (TLR7/9) to induce MyD88 oligomerization (MyDDosome) through TIR domain interactions. [11] MyD88 death domain (DD) and the intermediate domain (INT) are necessary for IL-1R-associated kinase (IRAK) binding, signaling transduction, and downstream NF-κB and IRF7 activation. [11,12] Stimulation of different TLRs triggers the association of MyD88 and induces distinct patterns of gene expression. [13,14] Recently, a study suggests that MyD88 could be rewired for glycolysis. [4] Thus, customized MyD88 signaling could not only be used for the activation of innate immunity but also to instruct the development of antigen-specific acquired immunity and metabolism. Similarly, the binding of viral RNA to RIG-I triggers RIG-I K63 polyubiquitination and mitochondrial translocation to engage and induce mitochondrial antiviral-signaling protein (MAVS) prion-like polymers (MAVSome), [15] which in turn induces TANK binding kinase 1 (TBK1)-IRF3 interaction to trigger IFN production. [16] Currently, the studies of Toll-like and RIG-I-like receptor signaling use synthetic PAMP ligands, such as poly(I:C) for TLR3 and RIG-I, LPS for TLR4, and CpG for TLR9. However, these reagents lack high signaling specificity because they can activate multiple cross-talking signaling pathways. For instance, dsRNA activates IFN pathways involving TLR3 and RIG-I/MDA5, as well as PRK (protein kinase K), to cause translational suppression; [17,18] whereas dsDNA activates TLR9, AIM2, and cGAS. [19] Potential ligand toxicity may also lead to acute cell death. [20] There remains, therefore, a criticalThe spatiotemporal organization of oligomeric protein complexes, such as the supramolecular organizing centers (SMOCs) made of MyDDosome and MAVSome, is essential for transcriptional activation of host inflammatory responses and immunometabolism. Light-inducible assembly of MyDDosome and MAVSome is presented herein to induce activation of nuclear factor-kB and type-I interferons. Enginee...